The molecular cartography of malignant and benign sebaceous tumours
Year: 2025
Type: article
Language: en
Topic: Nonmelanoma Skin Cancer Studies
Authors and affiliations:
raw_author_name: I. Ferreira
raw_affiliation_strings: Experimental Cancer Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom
Université Libre de Bruxelles, Brussels, Belgium
raw_author_name: O. M. Rueda
raw_affiliation_strings: MRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom
raw_author_name: L. van der Weyden
raw_affiliation_strings: Experimental Cancer Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom
raw_author_name: S. Sahni
raw_affiliation_strings: Cancer Data Science Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, United States of America
raw_author_name: O. Cast
raw_affiliation_strings: Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom
Experimental Cancer Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom
raw_author_name: K. Wong
raw_affiliation_strings: Experimental Cancer Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom
raw_author_name: M. Del Castillo Velasco-Herrera
raw_affiliation_strings: Experimental Cancer Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom
raw_author_name: H. Caldwell
raw_affiliation_strings: Edinburgh Pathology, Cancer Research UK Scotland Centre, The University of Edinburgh, Institute of Genetics & Cancer, Edinburgh, United Kingdom
raw_author_name: J. M. Boccacino
raw_affiliation_strings: Experimental Cancer Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom
raw_author_name: T. Alegbe
raw_affiliation_strings: European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, United Kingdom
Open Targets, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom
raw_author_name: I. Mehta
raw_affiliation_strings: Experimental Cancer Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom
raw_author_name: A. Gunjur
raw_affiliation_strings: Experimental Cancer Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom
raw_author_name: P. Gupta
raw_affiliation_strings: Experimental Cancer Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom
raw_author_name: V. Harle
raw_affiliation_strings: Experimental Cancer Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom
raw_author_name: K. Koga
raw_affiliation_strings: Department of Pathology, Faculty of Medicine, Fukuoka University Hospital, Fukuoka, Japan
raw_author_name: I. Matzusaki
raw_affiliation_strings: Department of Diagnostic Pathology, Wakayama Medical University, Wakayama, Japan
raw_author_name: M. Fujimoto
raw_affiliation_strings: Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan
Department of Diagnostic Pathology, Wakayama Medical University, Wakayama, Japan
raw_author_name: K. Wiedemeyer
raw_affiliation_strings: Department of Pathology & Laboratory Medicine, The Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Canada
Departments of Pathology and Dermatology, University of Michigan, Ann Arbor, Michigan, USA
raw_author_name: A. Stratigos
raw_affiliation_strings: 1st Department of Dermatology-Venereology, Andreas Sygros Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece
raw_author_name: A. Oniscu
raw_affiliation_strings: Department of Pathology and Cancer Diagnostics, Karolinska University Hospital Solna, Stockholm, Sweden
Edinburgh Pathology, Cancer Research UK Scotland Centre, The University of Edinburgh, Institute of Genetics & Cancer, Edinburgh, United Kingdom
raw_author_name: K. Wang
raw_affiliation_strings: Cancer Center at Illinois, University of Illinois Urbana-Champaign, Urbana, IL, USA
Cancer Data Science Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, United States of America
Department of Bioengineering, University of Illinois Urbana-Champaign, Urbana, IL, USA
Department of Comparative Biosciences, University of Illinois Urbana-Champaign, Urbana, IL, USA
raw_author_name: E. Ruppin
raw_affiliation_strings: Cancer Data Science Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, United States of America
raw_author_name: P. Demetter
raw_affiliation_strings: Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
Laboratory for Experiemental Gastroenterology, Université Libre de Bruxelles, Brussels, Belgium
Pathology department, CerbaPath, Division CMP, Brussels, Belgium
raw_author_name: I. M. Frayling
raw_affiliation_strings: Inherited Tumour Syndromes Research Group, Institute of Cancer & Genetics, School of Medicine, Cardiff University, Cardiff, UK
raw_author_name: M. J. Arends
raw_affiliation_strings: Edinburgh Pathology, Cancer Research UK Scotland Centre, The University of Edinburgh, Institute of Genetics & Cancer, Edinburgh, United Kingdom
raw_author_name: T. Brenn
raw_affiliation_strings: Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan
Department of Pathology & Laboratory Medicine, The Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Canada
raw_author_name: D. J. Adams
raw_affiliation_strings: Experimental Cancer Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom. da1@sanger.ac.uk
Experimental Cancer Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom